| Name | Title | Contact Details |
|---|---|---|
Kimberly Kralowetz |
Director of Information Security | Profile |
Kimberly K |
Director of Information Security | Profile |
Guru is the world`s first Revenue Empowerment Network, utilizing AI to make sales, support, and customer success teams better at their jobs. By empowering these teams in-context with the knowledge they need to respond to customer questions, they can stop spending time hunting down information and instead focus on what matters most — their customers.
strongDM`s infrastructure access network gives businesses confidence in their access and audit controls at scale. Adopted by companies ranging from the Fortune 500 to fast-growing businesses like Peloton, SoFi, and Betterment, strongDM gives infrastructure teams the convenience, visibility and control they need, without those controls getting in anyone`s way. strongDM is based everywhere and backed by Sequoia Capital and True Ventures.
KIRO Group provides Security, Technology, and Insurance solutions for Risk Management, Mitigation, Assessment and Governance strategies. Our Cybersecurity and Insurance experts provide unique solutions specifically catered for your organization through...
Cluen has decades of recruitment database development and implementation experience spanning six continents. Cluens solution, Encore, is used by executive search consultants, legal recruiters, in-house talent acquisition teams, government entities, un...
Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.